Literature DB >> 9188851

Immunological effects of an arginine side chain contaminating synthetically prepared peptides.

L J Schlagel1, L Bors, G W Mitchell, J L King, L Cao, M Kirk, J N Whitaker.   

Abstract

The side chain, 4-methoxy-2,3,6-trimethylbenzenesulphonyl (Mtr), is a protective group coupled to arginine to mask the omega-nitrogen, in order to protect the guanidino function during peptide synthesis by the 9-fluorenylmethoxycarbonyl (Fmoc) procedure (Walker, 1994). This group is removed at the completion of peptide synthesis; however, the cleavage process can be incomplete. We have found that animals injected with a mixed population of pure, i.e. unmodified, and Mtr-containing MBP peptides have an immunodominant humoral response to the Mtr-bearing peptide. This response is dependent on the characteristics of the MBP peptide involved. For two MBP peptides, the Mtr-containing peptide had increased binding to antibody over pure peptide. For two other peptides, only the Mtr-containing peptide bound antibody while the unmodified peptide did not. In a separate system involving a polyclonal response to an unrelated peptide from beta2-microglobulin (beta2 m), the dominance of the Mtr group was also evident. These results provide further evidence that a small side chain on a single amino acid in a peptide can markedly alter the immunogenicity and antigenicity of that peptide for antibody reactivity. This evidence emphasizes the need for a critical awareness of each component of peptide synthesis and its potential to alter the immunoreactivity of the final product.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188851     DOI: 10.1016/s0161-5890(97)00013-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

Review 1.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

2.  Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery.

Authors:  Martina Tuttolomondo; Cinzia Casella; Pernille Lund Hansen; Ester Polo; Luciana M Herda; Kenneth A Dawson; Henrik J Ditzel; Jan Mollenhauer
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-29       Impact factor: 8.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.